WKN: | A0LCUL |
ISIN: | US14888U1016 |
Land: | USA |
Branche: | Chemie, Pharma, Bio- & Medizintechnik |
Sektor: | Pharma |
Weshalb die Catalyst Pharm Partners-Aktie
ein A-Rating hat,
erfahren Sie im Performance-Check
vom 25. Juli 2025 Info.
Rang | Datum | Vorjahr | Schluss | Performance |
---|---|---|---|---|
1 | 2013 | 0,3400 | 1,5000 | 341,18% |
2 | 2017 | 0,9500 | 3,3400 | 251,58% |
3 | 2022 | 6,2800 | 16,9100 | 169,27% |
4 | 2021 | 2,7200 | 6,2800 | 130,88% |
5 | 2019 | 1,6900 | 3,3200 | 96,45% |
6 | 2010 | 0,4100 | 0,7100 | 73,17% |
7 | 2014 | 1,5000 | 2,3800 | 58,67% |
8 | 2024 | 15,4000 | 20,3300 | 32,01% |
9 | 2011 | 0,7100 | 0,9100 | 28,17% |
10 | 2015 | 2,3800 | 2,3100 | -2,94% |
11 | 2023 | 16,9100 | 15,4000 | -8,93% |
12 | 2025 | 20,3300 | 17,9700 | -11,61% |
13 | 2020 | 3,3200 | 2,7200 | -18,07% |
14 | 2007 | 3,3200 | 2,1100 | -36,45% |
15 | 2008 | 2,1100 | 1,1200 | -46,92% |
16 | 2018 | 3,3400 | 1,6900 | -49,40% |
17 | 2016 | 2,3100 | 0,9500 | -58,87% |
18 | 2012 | 0,9100 | 0,3400 | -62,64% |
19 | 2009 | 1,1200 | 0,4100 | -63,39% |
Rang | Datum | Vorjahr | Schluss | Performance |
---|---|---|---|---|
1 | 2009 | 1,1200 | 0,4100 | -63,39% |
2 | 2012 | 0,9100 | 0,3400 | -62,64% |
3 | 2016 | 2,3100 | 0,9500 | -58,87% |
4 | 2018 | 3,3400 | 1,6900 | -49,40% |
5 | 2008 | 2,1100 | 1,1200 | -46,92% |
6 | 2007 | 3,3200 | 2,1100 | -36,45% |
7 | 2020 | 3,3200 | 2,7200 | -18,07% |
8 | 2025 | 20,3300 | 17,9700 | -11,61% |
9 | 2023 | 16,9100 | 15,4000 | -8,93% |
10 | 2015 | 2,3800 | 2,3100 | -2,94% |
11 | 2011 | 0,7100 | 0,9100 | 28,17% |
12 | 2024 | 15,4000 | 20,3300 | 32,01% |
13 | 2014 | 1,5000 | 2,3800 | 58,67% |
14 | 2010 | 0,4100 | 0,7100 | 73,17% |
15 | 2019 | 1,6900 | 3,3200 | 96,45% |
16 | 2021 | 2,7200 | 6,2800 | 130,88% |
17 | 2022 | 6,2800 | 16,9100 | 169,27% |
18 | 2017 | 0,9500 | 3,3400 | 251,58% |
19 | 2013 | 0,3400 | 1,5000 | 341,18% |